Home States Delhi DCGI grants permission to Cipla to import Moderna’s COVID-19 vaccine for restricted...

DCGI grants permission to Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country

268
0
SHARE
(G.N.S) Dt. 29 New Delhi New drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use: Dr. VK Paul, Member-Health, Niti Aayog. DCGI has granted permission to pharmaceutical company Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country. Moderna’s vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin, and Sputnik.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In